The Value of Integrating Visual Arts: Evaluating the Benefits of Hospital Room Artwork on Inpatient Wellbeing
VIVA
1 other identifier
interventional
184
1 country
1
Brief Summary
The Value of Integrating Visual Arts (VIVA): Evaluating the Benefits of Hospital Room Artwork on Inpatient Wellbeing will use a large randomized controlled trial design to investigate how the inclusion of visual arts in the hospital rooms of cancer patients benefits their quality-of-life during treatment. This 18-month research study will provide hospitals with evidence of the therapeutic value of the visual arts as measured by patients' perceptions of anxiety, pain ratings, use of pain medications, need for nurses, and length of stay. Data also will be collected on patients' evaluation of hospital rooms, specifically on décor including artwork, so as to correlate patient wellbeing with the presence of artwork. Ultimately, this project aims to increase support of and appreciation for the arts from a major consumer-namely, healthcare providers-by justifying the value of integrating local visual art into inpatient rooms and providing patients with aesthetic choice during their stay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Nov 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 29, 2015
CompletedFirst Posted
Study publicly available on registry
February 6, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedSeptember 13, 2016
September 1, 2016
1.4 years
January 29, 2015
September 12, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Perceptions of anxiety as measured by the State-Trait Anxiety Inventory for Adults
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Secondary Outcomes (3)
Reports of pain as drawn for each patient via PowerChart, the hospital's electronic medical record software for documenting patient care
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Use of pain medications as drawn for each patient via PowerChart, the hospital's electronic medical record software for documenting patient care
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Mood as measured by the Mitchell Emotional Thermometer
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Study Arms (3)
Choice
EXPERIMENTALPatients given choice over artwork on wall
No choice
ACTIVE COMPARATORPatients not given choice over artwork on wall
No artwork
PLACEBO COMPARATORPatients not receiving any artwork on wall
Interventions
Prints by local artists that are hung on the walls of patient rooms.
Eligibility Criteria
You may qualify if:
- Patients who are admitted to the Penn State Hershey Cancer Institute (7th floor) for treatments including oncology, bone marrow transplant, and hematology. Patients will be 18 years or older
You may not qualify if:
- Patients whose treatments do not include oncology, bone marrow transplant, and hematology; who are not hospitalized on the 7th floor of the Cancer Institute; and who are not 18 years or older.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Penn State Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
Related Publications (1)
George DR, Boer C, Hammer J, Hopkins M, King T, Green MJ. Evaluating the Benefits of Hospital Room Artwork for Patients Receiving Cancer Treatment: A Randomized Controlled Trial. J Hosp Med. 2018 Aug 1;13(8):558-561. doi: 10.12788/jhm.2915. Epub 2018 Feb 5.
PMID: 29401210DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel George, PhD
Penn State College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 29, 2015
First Posted
February 6, 2015
Study Start
November 1, 2014
Primary Completion
April 1, 2016
Study Completion
August 1, 2016
Last Updated
September 13, 2016
Record last verified: 2016-09